MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Ovid Therapeutics Inc. (NASDAQ: OVID)*
Organization & Developments: Ovid Therapeutics
Parents
Ovid Therapeutics Inc. (NASDAQ: OVID)*
Children
2019: Ovid Therapeutics: High Risk/High Reward_seekingalpha.com
2020: Ovid Advances Fragile X Syndrome Drug Forward; Multiple Catalysts Still Expected In 2020
2020: Ovid flunks Angelman phase 3, leaving field wide open for rivals
2020: Ovid Therapeutics: A Full Investment Analysis
2020: Ovid Therapeutics: Strong Buy After Fall On Necessary Dilution Backed By Positive Data
2021: Ovid Therapeutics: Residual Value In OV935 After The OV101 Fiasco
2022: Ovid joins the restructuring movement, laying off staff as Jeremy Levin's crew refocuses on epilepsy
2024: Ovid Therapeutics: Data Readouts For Rare Epileptic Indications Late 2024
Jumps
*Key People: Ovid Therapeutics
Finance & Acquisitions: Ovid Therapeutics